Fibromyalgia Project Wins One of Three Purdue Pharma Research Grants for Chronic Pain and Pain Assessment

Fibromyalgia Project Wins One of Three Purdue Pharma Research Grants for Chronic Pain and Pain Assessment
A research project focused on developing an objective measure of pain-related interference with cognitive performance in people with fibromyalgia is one of three awarded research grants recently by Purdue Pharma. An independent steering committee oversaw the competition and selection of the three recipients of Purdue’s research grants to study chronic pain and the assessment of pain. Robert R. Edwards, PhD, of the Brigham and Women’s Hospital at the Harvard Medical School in Boston, will lead the project dedicated to pain in fibromyalgia. The project is titled “Development and application of an objective measure of pain-related interference with cognition.” The goal is to identify a set of cognitive tasks that are affected by variations in pain levels when they are being performed. Once an appropriate set of tasks is developed, they will be used in a randomized, controlled trial to test an intervention designed to improve cognitive performance in this patient population. Another of the selected projects, led by David A. Seminowicz, PhD, at the University of Maryland School of Dentistry, Baltimore, is titled “Development of a reliable neurophysiological pain assessment tool: alpha as a predictive biomarker (APB).” This study aims to determine if EEG alpha wave activity is an accurate and reliable measure of acute pain and neuropathic pain (chronic pain resulting from injury to
Subscribe or to access all post and page content.

One comment

  1. Jane says:

    Chorionic pain is a serious problem, I broke my ankle 3 years ago, and when the weather changes, I suffer severe pains, it’s unbearable, doctors can not help me either, my friend recommended drugs based on bee venom, now I’m looking for information about contraindications.

Leave a Comment

Your email address will not be published. Required fields are marked *